-transparent.png){kind=logo}
Alpha-1-antitrypsin phenotypes were determined in 37 patients with rheumatoid arthritis and 40 patients with systemic lupus erythematosus. No significant increase in non-MM phenotypes was found. It appears that alpha-1-antitrypsin phenotypes neither predispose to the development nor enhance the severity of the two rheumatic diseases.
Related Publications
J Karsh, and
J Vergalla, and
E A Jones
August 1987,
Arthritis and rheumatism,
J Karsh, and
J Vergalla, and
E A Jones
October 1977,
Lancet (London, England),
J Karsh, and
J Vergalla, and
E A Jones
January 1984,
Medicina clinica,
J Karsh, and
J Vergalla, and
E A Jones
March 1995,
The West Indian medical journal,
J Karsh, and
J Vergalla, and
E A Jones
November 1977,
Lancet (London, England),
J Karsh, and
J Vergalla, and
E A Jones
January 1977,
Lancet (London, England),
J Karsh, and
J Vergalla, and
E A Jones
January 1970,
Naika. Internal medicine,
J Karsh, and
J Vergalla, and
E A Jones
March 1958,
Annals of the rheumatic diseases,
J Karsh, and
J Vergalla, and
E A Jones
June 1995,
Lupus,
J Karsh, and
J Vergalla, and
E A Jones
January 1989,
Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College = Chung-kuo i hsueh k'o hsueh yuan, Chung-kuo hsieh ho i k'o ta hsueh hsueh pao,
